No Detail Found!

In-vitro evaluation of antiproliferative potential of various fractions of Silybum marianum using HeLa and HepG2 cell lines

Author(s)
Aisha Nawaz Department of Biochemistry, University of Central Punjab,Lahore,Pakistan
Tanzeela Riaz Department of Biochemistry, University of Central Punjab,Lahore,Pakistan
Abrar Ahmad University College of Pharmacy, University of Punjab,Lahore,Pakistan
Abstract
Silybum marianum (Milk thistle) has been proven to possess anticancer, lactogenic, neuroprotective, immunomodulatory, hepatoprotective and anti-inflammatory properties. The current study was designed to evaluate the antiproliferative potential of aqueous and various organic fractions (ethanolic, petroleum ether, ethyl acetate, chloroform, n-butanol) of S. marianum against cancerous [HeLa, HepG2] and noncancerous [BHK] cell lines. The MTT assay was performed to access the cytotoxicity of all these fractions and IC50 values were calculated. The cytotoxicity of these fractions was also confirmed through crystal violet and Trypan blue assays. All the tested fractions of S. marianum possessed significant antiproliferative potential. Interestingly, ethyl acetate fraction of S. marianum exhibited the highest antiproliferative activity amongst all the other tested fractions with an IC50 of 13.07 µg/ml, 18.92 µg/ml and 76.15µg/ml against HeLa, HepG2 and BHK cell lines respectively. So it is concluded that S. marianum possess strong anticancer activity against both cervical and liver cancer and low cytotoxicity against normal cell line so it could be used as a source of potent anticancer compounds having high efficacy and minimal side effects.
Publication Details
Page(s) 755-760
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP2, Year: 2021

Request the full text from PASTIC

Keywords
5-Dimethylthiazol-2-yl)-2, Silybum marianum, cancerous cells, 5-diphenyltetrazolium assay, 3-(4, normal cells, antiproliferative potential
References
Agyarea C,Spieglerc V,Asaseb A,Scholzc M,Hempeld G,Hense A .2018 .An ethnopharmacological survey of medicinal plants traditionally used for cancer treatment in the Ashanti region. , 212(2) : 137-152.
Almosnida NM,Xiaolei Z,Lihe J,Amy R,Deborah K,Shuo W,Fan W,Jingquan Y,Elliot A,Ying G,Jianhua M .2018 .Evaluation of extracts prepared from 16 plants used in Yao ethnomedicine as potential anticancer agents. J. Ethnopharmacol., 211(1) : 224-234.
Andima M,Coghi P,Yang LJ,Wong VKW,Ngule CM,Heydenreich M,Ndakala AJ,Yenesew A,Derese S A .2020 .Antiproliferative activity of secondary metabolites from Zanthoxylum zanthoxyloides Lam: In vitro and in silico Studies. , 10(1) : 44-51.
Biseko EZ,Swai HS,Mbugua RW,Ndungu JW,Chepngetich J,Gathirwa JW .2019 .In vitro antiproliferative potential of Annona senegalensis Pers. and Allophylus africanus P Beauv. plant extracts against selected cancer cell lines. J. Med. Plants Res., 13(13) : 304-311.
Chanchal DK,Alok S,Rashi S,Bijauliya RK,Yadav RD,Sabharwal M .2018 .Various medicinal plants used in the treatment of anticancer activity. Int. J. Pharm. Sci. Res, 9(4) : 1424-1429.
Chandrasekar R,Sivagami B,Niranjan BM B .2018 .A pharmacoeconomic focus on medicinal plants with anticancer activity. Res. J. Pharmacog. Phytochem., 10(1) : 91-100.
Choe U,Whent M,Luo Y,Yu L Y .2020 .Total phenolic content, free radical scavenging capacity, and anticancer activity of silymarin. J. Food Bioact, 10(6) : 53-63.
Davis-Searles PR,Nakanishi Y,Kim N,Graf TN,Oberlies NH,Wani MC,Wall ME,Agarwal R,Kroll DJ R .2014 .Milk thistle and prostate cancer: Differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res., 65(10) : 4448-4457.
Gioti K,Papachristodoulou A,Benaki D,Havaki S,Beloukas A,Vontzalidou A,Aligiannis N,Skaltsounis AL,Mikros E,Tenta R .2019 .Silymarin enriched extract (Silybum marianum) additive effect on doxorubicin-mediated cytotoxicity in PC-3 prostate cancer cells. Planta Med, 85(11) : 997-1007.
Khan T,Amrita D,Hardik C,Krina P C .2019 .Polysaccharides as potential anticancer agents-A review of their progress. Carbohydrate polymer., 210(4) : 412-428.
Kim SH,Choo G,Yoo E,Woo J,Han S,Lee J,Jung J .2019 .Silymarin induces inhibition of growth and apoptosis through modulation of the MAPK signaling pathway in AGS human gastric cancer cells. Oncol. Rep, 42(5) : 1904-1914.
Kimani PM,Mwitari PG,Njagi SM,Kirira PG,Kiboi DM .2018 .In vitro anti-Proliferative activity of selected plant extracts against cervical and prostate cancer cell lines. J. Cancer Sci. Ther, 10(9) : 267-271.
Liang C,Pan H,Li H,Zhao Y,Feng Y Y .2017 .In vitro anticancer activity and cytotoxicity screening of phytochemical extracts from selected traditional Chinese medicinal plants. JBUON, 22(2) : 543-551.
Maqbool T,Awan SJ,Malik S,Hadi F,Shehzadi S,Tariq K S .2019 .In-vitro anti-proliferative, apoptotic and antioxidative activities of medicinal herb Kalonji (Nigella sativa). Current Pharmaceut, 20(15) : 1-21.
Panth N,Manandhar B,Paudel KR B .2017 .Anticancer activity of Punica granatum (Pomegranate): A review. Phytother. Res., 31(4) : 568-578.
Privitera G,Luca T,Castorina S,Passanisi R,Ruberto G,Napoli E .2019 .Anticancer activity of Salvia officinalis essential oil and its principal constituents against hormone-dependent tumour cells. Asian. Pac. J. Trop. Biomed., 9(1) : 24-28.
Singh S,Mehta A,Baweja S,Ahirwal L,Mehta P .2013 .Anticancer activity of Andrographis paniculata and Silybum marianum on five human cancer cell lines. J. pharmacol. toxicol., 8(1) : 42-48.
Valkova V,Duranova H,Bilcikova J,Haban M .2020 .Milk thistle (Silybum marianum): A valuable medicinal plant with several therapeutic purposes. J. Microbiol. Biotech. Food Sci., 9(4) : 836-843.
Wang X,Zhang Z,Wu SC .2020 .Health Benefits of Silybum marianum: Phytochemistry, pharmacology, and applications. J. Agric. Food Chem, 68(42) : 11644-11664.
Wiseman MJ .2019 .Nutrition and cancer: Prevention and survival. British J. Nutri., 122(5) : 481-487.
Zahira NV,Nakhjavania M,Hajianb P,Shirazic FH,Mirzaeie H FH .2018 .Evaluation of silibinin effects on the viability of HepG2 (human hepatocellular liver carcinoma) and HUVEC (human umbilical vein endothelial) cell lines. Iranian J. Pharmaceutic Res., 17(1) : 261-267.
0

Citations

0

Downloads

11

Views